Global Extremities Market Size 2022 - Allied Market Research

Upcoming

2023

Extremities Market

by Product (Upper extremities, Lower extremities): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies	Report Code: A01217	Nov 2023 \| Pages: NA
Tables: NA	Charts: NA	Formats*: Single User License, Five User License & Enterprise User License Data Pack Excel License It comes with the additional cost of $2500.00 contact sales.

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Extremities Market

Request Now !

Body extremities are extended organs mainly involved in locomotive functions. The human body has four extremities i.e. two upper limbs and two lower limbs. The extremities market is a small portion of the orthopedic industry. The joint reconstruction procedures involve modification of the body extremities. The human skeleton has more than 200 bones which are supported by tendons, ligaments and muscles. Hence, the prime focus of orthopedic industries was manufacture of devices and treatment procedures for joints, spine, knee and hip. But, now-a-days the focus of leading players on extremities market is increasing day by day as they offer better treatment options and provide growth opportunities to the key players.

The world extremities market is driven by the increase in the number of cases for orthopedic surgeons several factors such as increase in ageing population, awareness of the people for better treatment options and their expectations for a good quality of living. In addition, changes in the clinical practice patterns such as use of reversed shoulder instead of anatomic shoulder, use of arthroplasty procedure as an alternative to ankle fusion and increased use of implants in foot and ankle surgeries will also boost the market growth. Apart from this, development of new improved shoulders and ankles and need for less invasive devices will further propel the market growth. But the high unmet need for early diagnosis due to long waiting time in some countries is expected to hamper the market growth.

World extremities market is segmented on the basis of products and geography. Based on products, the market is segmented mainly into upper extremities and lower extremities. Upper extremities segment is further sub segmented into shoulder, elbow and hand & wrist. Lower extremities segment is further sub segmented into knee, hip and foot & ankle. The geographical classification includes North America, Europe, Asia-Pacific and LAMEA regions.

As the extremities market is in the expansion phase, mergers and acquisitions are frequent in this market. In October 2015 Wright Medical Group, Inc. and Tornier N.V merged together to form Wright Medical Group N.V. This has helped the company to establish themselves as the premier, high-growth extremities-biologics company and extend its leadership position and further accelerate its growth opportunities.
Key players in this market include DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson), Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Integra Lifesciences Holdings Corporation, Wright Medical Group N.V., Exactech, Inc., Arthrex, Inc., CONMED Corporation and Skeletal Dynamics LLC.

KEY MARKET BENEFITS:

The study provides an in-depth analysis of the world extremities market with current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis by product helps in understanding the various types of devices used.
Competitive intelligence highlights the business practices followed by leading players across various regions.
Comprehensive analysis of all geographic regions are provided that helps in determining the prevailing opportunities in these geographies
Key market players within the world extremities market are profiled in the report and their strategies are analysed thoroughly, which helps in understanding competitive outlook of the global market
Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework

Extremities Market Report Highlights

Aspects	Details
By Product	Upper extremities Shoulder Elbow Hand & wrist Lower extremities Hip Knee Foot & ankle
By Region	North America (U.S., Canada, Mexico) Europe (France, Germany, UK, Rest of Europe) Asia-Pacific (China, Japan, India, Rest of Asia-Pacific) LAMEA (Brazil, South Africa, Egypt, Rest of LAMEA)
Key Market Players	Skeletal Dynamics LLC., Exactech, Inc., Arthrex, Inc., Zimmer Biomet Holdings, Inc., Wright Medical Group N.V., DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson), Stryker Corporation, Smith & Nephew plc, CONMED Corporation, Integra Lifesciences Holdings Corporation

CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
  - 1.4.1. Primary Research
  - 1.4.2. Secondary Research
  - 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
  - 3.2.1. Top Investment Pockets
  - 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
  - 3.3.1. Bargaining Power of Suppliers
  - 3.3.2. Threat of New Entrants
  - 3.3.3. Threat of Substitutes
  - 3.3.4. Competitive Rivalry
  - 3.3.5. Bargaining Power among Buyers
- 3.5. Market Dynamics
  - 3.5.1. Drivers
  - 3.5.2. Restraints
  - 3.5.3. Opportunities
- 3.6. COVID-19 Impact Analysis
CHAPTER 4: EXTREMITIES MARKET, BY PRODUCT
- 4.1. Market Overview
  - 4.1.1 Market Size and Forecast, By Product
- 4.2. Upper Extremities
  - 4.2.1. Key Market Trends, Growth Factors and Opportunities
  - 4.2.2. Market Size and Forecast, By Region
  - 4.2.3. Market Share Analysis, By Country
  - 4.2.4. Shoulder
    - 4.2.4.1. Market Size and Forecast
  - 4.2.4. Elbow
    - 4.2.4.1. Market Size and Forecast
  - 4.2.4. Hand wrist
    - 4.2.4.1. Market Size and Forecast
- 4.3. Lower Extremities
  - 4.3.1. Key Market Trends, Growth Factors and Opportunities
  - 4.3.2. Market Size and Forecast, By Region
  - 4.3.3. Market Share Analysis, By Country
  - 4.3.4. Hip
    - 4.3.4.1. Market Size and Forecast
  - 4.3.4. Knee
    - 4.3.4.1. Market Size and Forecast
  - 4.3.4. Foot ankle
    - 4.3.4.1. Market Size and Forecast
CHAPTER 5: EXTREMITIES MARKET, BY REGION
- 5.1. Market Overview
  - 5.1.1 Market Size and Forecast, By Region
- 5.2. North America
  - 5.2.1. Key Market Trends and Opportunities
  - 5.2.2. Market Size and Forecast, By Product
  - 5.2.3. Market Size and Forecast, By Country
  - 5.2.4. U.S. Extremities Market
    - 5.2.4.1. Market Size and Forecast, By Product
  - 5.2.5. Canada Extremities Market
    - 5.2.5.1. Market Size and Forecast, By Product
  - 5.2.6. Mexico Extremities Market
    - 5.2.6.1. Market Size and Forecast, By Product
- 5.3. Europe
  - 5.3.1. Key Market Trends and Opportunities
  - 5.3.2. Market Size and Forecast, By Product
  - 5.3.3. Market Size and Forecast, By Country
  - 5.3.4. France Extremities Market
    - 5.3.4.1. Market Size and Forecast, By Product
  - 5.3.5. Germany Extremities Market
    - 5.3.5.1. Market Size and Forecast, By Product
  - 5.3.6. Italy Extremities Market
    - 5.3.6.1. Market Size and Forecast, By Product
  - 5.3.7. Spain Extremities Market
    - 5.3.7.1. Market Size and Forecast, By Product
  - 5.3.8. UK Extremities Market
    - 5.3.8.1. Market Size and Forecast, By Product
  - 5.3.9. Russia Extremities Market
    - 5.3.9.1. Market Size and Forecast, By Product
  - 5.3.10. Rest Of Europe Extremities Market
    - 5.3.10.1. Market Size and Forecast, By Product
- 5.4. Asia-Pacific
  - 5.4.1. Key Market Trends and Opportunities
  - 5.4.2. Market Size and Forecast, By Product
  - 5.4.3. Market Size and Forecast, By Country
  - 5.4.4. China Extremities Market
    - 5.4.4.1. Market Size and Forecast, By Product
  - 5.4.5. Japan Extremities Market
    - 5.4.5.1. Market Size and Forecast, By Product
  - 5.4.6. India Extremities Market
    - 5.4.6.1. Market Size and Forecast, By Product
  - 5.4.7. South Korea Extremities Market
    - 5.4.7.1. Market Size and Forecast, By Product
  - 5.4.8. Australia Extremities Market
    - 5.4.8.1. Market Size and Forecast, By Product
  - 5.4.9. Thailand Extremities Market
    - 5.4.9.1. Market Size and Forecast, By Product
  - 5.4.10. Malaysia Extremities Market
    - 5.4.10.1. Market Size and Forecast, By Product
  - 5.4.11. Indonesia Extremities Market
    - 5.4.11.1. Market Size and Forecast, By Product
  - 5.4.12. Rest of Asia Pacific Extremities Market
    - 5.4.12.1. Market Size and Forecast, By Product
- 5.5. LAMEA
  - 5.5.1. Key Market Trends and Opportunities
  - 5.5.2. Market Size and Forecast, By Product
  - 5.5.3. Market Size and Forecast, By Country
  - 5.5.4. Brazil Extremities Market
    - 5.5.4.1. Market Size and Forecast, By Product
  - 5.5.5. South Africa Extremities Market
    - 5.5.5.1. Market Size and Forecast, By Product
  - 5.5.6. Saudi Arabia Extremities Market
    - 5.5.6.1. Market Size and Forecast, By Product
  - 5.5.7. UAE Extremities Market
    - 5.5.7.1. Market Size and Forecast, By Product
  - 5.5.8. Argentina Extremities Market
    - 5.5.8.1. Market Size and Forecast, By Product
  - 5.5.9. Rest of LAMEA Extremities Market
    - 5.5.9.1. Market Size and Forecast, By Product
CHAPTER 6: COMPETITIVE LANDSCAPE
- 6.1. Introduction
- 6.2. Top Winning Strategies
- 6.3. Product Mapping Of Top 10 Player
- 6.4. Competitive Dashboard
- 6.5. Competitive Heatmap
- 6.6. Top Player Positioning,2022
CHAPTER 7: COMPANY PROFILES
- 7.1. DePuy Synthes (a Wholly Owned Subsidiary Of Johnson And Johnson)
  - 7.1.1. Company Overview
  - 7.1.2. Key Executives
  - 7.1.3. Company Snapshot
  - 7.1.4. Operating Business Segments
  - 7.1.5. Product Portfolio
  - 7.1.6. Business Performance
  - 7.1.7. Key Strategic Moves and Developments
- 7.2. Stryker Corporation
  - 7.2.1. Company Overview
  - 7.2.2. Key Executives
  - 7.2.3. Company Snapshot
  - 7.2.4. Operating Business Segments
  - 7.2.5. Product Portfolio
  - 7.2.6. Business Performance
  - 7.2.7. Key Strategic Moves and Developments
- 7.3. Zimmer Biomet Holdings, Inc.
  - 7.3.1. Company Overview
  - 7.3.2. Key Executives
  - 7.3.3. Company Snapshot
  - 7.3.4. Operating Business Segments
  - 7.3.5. Product Portfolio
  - 7.3.6. Business Performance
  - 7.3.7. Key Strategic Moves and Developments
- 7.4. Smith And Nephew Plc
  - 7.4.1. Company Overview
  - 7.4.2. Key Executives
  - 7.4.3. Company Snapshot
  - 7.4.4. Operating Business Segments
  - 7.4.5. Product Portfolio
  - 7.4.6. Business Performance
  - 7.4.7. Key Strategic Moves and Developments
- 7.5. Integra Lifesciences Holdings Corporation
  - 7.5.1. Company Overview
  - 7.5.2. Key Executives
  - 7.5.3. Company Snapshot
  - 7.5.4. Operating Business Segments
  - 7.5.5. Product Portfolio
  - 7.5.6. Business Performance
  - 7.5.7. Key Strategic Moves and Developments
- 7.6. Wright Medical Group N.V.
  - 7.6.1. Company Overview
  - 7.6.2. Key Executives
  - 7.6.3. Company Snapshot
  - 7.6.4. Operating Business Segments
  - 7.6.5. Product Portfolio
  - 7.6.6. Business Performance
  - 7.6.7. Key Strategic Moves and Developments
- 7.7. Exactech, Inc.
  - 7.7.1. Company Overview
  - 7.7.2. Key Executives
  - 7.7.3. Company Snapshot
  - 7.7.4. Operating Business Segments
  - 7.7.5. Product Portfolio
  - 7.7.6. Business Performance
  - 7.7.7. Key Strategic Moves and Developments
- 7.8. Arthrex, Inc.
  - 7.8.1. Company Overview
  - 7.8.2. Key Executives
  - 7.8.3. Company Snapshot
  - 7.8.4. Operating Business Segments
  - 7.8.5. Product Portfolio
  - 7.8.6. Business Performance
  - 7.8.7. Key Strategic Moves and Developments
- 7.9. CONMED Corporation
  - 7.9.1. Company Overview
  - 7.9.2. Key Executives
  - 7.9.3. Company Snapshot
  - 7.9.4. Operating Business Segments
  - 7.9.5. Product Portfolio
  - 7.9.6. Business Performance
  - 7.9.7. Key Strategic Moves and Developments
- 7.10. Skeletal Dynamics LLC.
  - 7.10.1. Company Overview
  - 7.10.2. Key Executives
  - 7.10.3. Company Snapshot
  - 7.10.4. Operating Business Segments
  - 7.10.5. Product Portfolio
  - 7.10.6. Business Performance
  - 7.10.7. Key Strategic Moves and Developments

LIST OF TABLES
TABLE 1. GLOBAL EXTREMITIES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 2. GLOBAL EXTREMITIES MARKET FOR UPPER EXTREMITIES, BY REGION, 2022-2032 ($MILLION)
TABLE 3. GLOBAL EXTREMITIES MARKET FOR LOWER EXTREMITIES, BY REGION, 2022-2032 ($MILLION)
TABLE 4. GLOBAL EXTREMITIES MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 5. NORTH AMERICA EXTREMITIES, BY REGION, 2022-2032 ($MILLION)
TABLE 6. NORTH AMERICA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 7. U.S. EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 8. CANADA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 9. MEXICO EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 10. EUROPE EXTREMITIES, BY REGION, 2022-2032 ($MILLION)
TABLE 11. EUROPE EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 12. FRANCE EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 13. GERMANY EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 14. ITALY EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 15. SPAIN EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 16. UK EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 17. RUSSIA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 18. REST OF EUROPE EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 19. ASIA-PACIFIC EXTREMITIES, BY REGION, 2022-2032 ($MILLION)
TABLE 20. ASIA-PACIFIC EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 21. CHINA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 22. JAPAN EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 23. INDIA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 24. SOUTH KOREA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 25. AUSTRALIA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 26. THAILAND EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 27. MALAYSIA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 28. INDONESIA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 29. REST OF ASIA PACIFIC EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 30. LAMEA EXTREMITIES, BY REGION, 2022-2032 ($MILLION)
TABLE 31. LAMEA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 32. BRAZIL EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 33. SOUTH AFRICA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 34. SAUDI ARABIA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 35. UAE EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 36. ARGENTINA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 37. REST OF LAMEA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 38. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): KEY EXECUTIVES
TABLE 39. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): COMPANY SNAPSHOT
TABLE 40. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): OPERATING SEGMENTS
TABLE 41. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): PRODUCT PORTFOLIO
TABLE 42. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 43. STRYKER CORPORATION: KEY EXECUTIVES
TABLE 44. STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 45. STRYKER CORPORATION: OPERATING SEGMENTS
TABLE 46. STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 47. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 48. ZIMMER BIOMET HOLDINGS, INC.: KEY EXECUTIVES
TABLE 49. ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 50. ZIMMER BIOMET HOLDINGS, INC.: OPERATING SEGMENTS
TABLE 51. ZIMMER BIOMET HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 52. ZIMMER BIOMET HOLDINGS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 53. SMITH AND NEPHEW PLC: KEY EXECUTIVES
TABLE 54. SMITH AND NEPHEW PLC: COMPANY SNAPSHOT
TABLE 55. SMITH AND NEPHEW PLC: OPERATING SEGMENTS
TABLE 56. SMITH AND NEPHEW PLC: PRODUCT PORTFOLIO
TABLE 57. SMITH AND NEPHEW PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 58. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY EXECUTIVES
TABLE 59. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 60. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OPERATING SEGMENTS
TABLE 61. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 62. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 63. WRIGHT MEDICAL GROUP N.V.: KEY EXECUTIVES
TABLE 64. WRIGHT MEDICAL GROUP N.V.: COMPANY SNAPSHOT
TABLE 65. WRIGHT MEDICAL GROUP N.V.: OPERATING SEGMENTS
TABLE 66. WRIGHT MEDICAL GROUP N.V.: PRODUCT PORTFOLIO
TABLE 67. WRIGHT MEDICAL GROUP N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 68. EXACTECH, INC.: KEY EXECUTIVES
TABLE 69. EXACTECH, INC.: COMPANY SNAPSHOT
TABLE 70. EXACTECH, INC.: OPERATING SEGMENTS
TABLE 71. EXACTECH, INC.: PRODUCT PORTFOLIO
TABLE 72. EXACTECH, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 73. ARTHREX, INC.: KEY EXECUTIVES
TABLE 74. ARTHREX, INC.: COMPANY SNAPSHOT
TABLE 75. ARTHREX, INC.: OPERATING SEGMENTS
TABLE 76. ARTHREX, INC.: PRODUCT PORTFOLIO
TABLE 77. ARTHREX, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 78. CONMED CORPORATION: KEY EXECUTIVES
TABLE 79. CONMED CORPORATION: COMPANY SNAPSHOT
TABLE 80. CONMED CORPORATION: OPERATING SEGMENTS
TABLE 81. CONMED CORPORATION: PRODUCT PORTFOLIO
TABLE 82. CONMED CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 83. SKELETAL DYNAMICS LLC.: KEY EXECUTIVES
TABLE 84. SKELETAL DYNAMICS LLC.: COMPANY SNAPSHOT
TABLE 85. SKELETAL DYNAMICS LLC.: OPERATING SEGMENTS
TABLE 86. SKELETAL DYNAMICS LLC.: PRODUCT PORTFOLIO
TABLE 87. SKELETAL DYNAMICS LLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES
FIGURE 1. GLOBAL EXTREMITIES MARKET SEGMENTATION
FIGURE 2. GLOBAL EXTREMITIES MARKET
FIGURE 3. SEGMENTATION EXTREMITIES MARKET
FIGURE 4. TOP INVESTMENT POCKET IN EXTREMITIES MARKET
FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
FIGURE 8. LOW THREAT OF SUBSTITUTION
FIGURE 9. HIGH COMPETITIVE RIVALRY
FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALEXTREMITIES MARKET
FIGURE 11. EXTREMITIES MARKET SEGMENTATION, BY BY PRODUCT
FIGURE 12. EXTREMITIES MARKET FOR UPPER EXTREMITIES, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 13. EXTREMITIES MARKET FOR LOWER EXTREMITIES, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 14. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 18. COMPETITIVE DASHBOARD
FIGURE 19. COMPETITIVE HEATMAP: EXTREMITIES MARKET
FIGURE 20. Top player positioning, 2022
FIGURE 21. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): NET SALES, 2020-2022 ($MILLION)
FIGURE 22. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 23. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 24. STRYKER CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 25. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 26. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 27. ZIMMER BIOMET HOLDINGS, INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 28. ZIMMER BIOMET HOLDINGS, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 29. ZIMMER BIOMET HOLDINGS, INC.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 30. SMITH AND NEPHEW PLC: NET SALES, 2020-2022 ($MILLION)
FIGURE 31. SMITH AND NEPHEW PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 32. SMITH AND NEPHEW PLC: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 33. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 34. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 35. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 36. WRIGHT MEDICAL GROUP N.V.: NET SALES, 2020-2022 ($MILLION)
FIGURE 37. WRIGHT MEDICAL GROUP N.V.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 38. WRIGHT MEDICAL GROUP N.V.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 39. EXACTECH, INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 40. EXACTECH, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 41. EXACTECH, INC.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 42. ARTHREX, INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 43. ARTHREX, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 44. ARTHREX, INC.: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 45. CONMED CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 46. CONMED CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 47. CONMED CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 48. SKELETAL DYNAMICS LLC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 49. SKELETAL DYNAMICS LLC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 50. SKELETAL DYNAMICS LLC.: REVENUE SHARE, BY REGION, 2032 (%)

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

U.S.-Canada Toll-free: +1-800-792-5285
Int'l :	+1-503-894-6022
Europe :	+44-845-528-1300
Email :	help@alliedmarketresearch.com

Life Sciences	Construction & Manufacturing	Semiconductor & Electronics
Consumer Goods	Food & Beverages	Automotive & Tarnsportation
Materials & Chemicals	Energy & Power	ICT & Media
Aerospace & Defense	BFSI
You must check at least one industry.

Your Shopping Cart Is Empty

Continue Shopping

Extremities Market Global Opportunity Analysis and Industry Forecast, 2023-2032

2023

Extremities Market

Extremities Market

by Product (Upper extremities, Lower extremities): Global Opportunity Analysis and Industry Forecast, 2023-2032

COVID-19

CHAPTER 1: INTRODUCTION

1.1. Report Description

1.2. Key Market Segments

1.3. Key Benefits

1.4. Research Methodology

1.4.1. Primary Research

1.4.2. Secondary Research

1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope

3.2. Key Findings

3.2.1. Top Investment Pockets

3.2.2. Top Winning Strategies

3.3. Porter's Five Forces Analysis

3.3.1. Bargaining Power of Suppliers

3.3.2. Threat of New Entrants

3.3.3. Threat of Substitutes

3.3.4. Competitive Rivalry

3.3.5. Bargaining Power among Buyers

3.5. Market Dynamics

3.5.1. Drivers

3.5.2. Restraints

3.5.3. Opportunities

3.6. COVID-19 Impact Analysis

CHAPTER 4: EXTREMITIES MARKET, BY PRODUCT

4.1. Market Overview

4.1.1 Market Size and Forecast, By Product

4.2. Upper Extremities

4.2.1. Key Market Trends, Growth Factors and Opportunities

4.2.2. Market Size and Forecast, By Region

4.2.3. Market Share Analysis, By Country

4.2.4. Shoulder

4.2.4.1. Market Size and Forecast

4.2.4. Elbow

4.2.4.1. Market Size and Forecast

4.2.4. Hand wrist

4.2.4.1. Market Size and Forecast

4.3. Lower Extremities

4.3.1. Key Market Trends, Growth Factors and Opportunities

4.3.2. Market Size and Forecast, By Region

4.3.3. Market Share Analysis, By Country

4.3.4. Hip

4.3.4.1. Market Size and Forecast

4.3.4. Knee

4.3.4.1. Market Size and Forecast

4.3.4. Foot ankle

4.3.4.1. Market Size and Forecast

CHAPTER 5: EXTREMITIES MARKET, BY REGION

5.1. Market Overview

5.1.1 Market Size and Forecast, By Region

5.2. North America

5.2.1. Key Market Trends and Opportunities

5.2.2. Market Size and Forecast, By Product

5.2.3. Market Size and Forecast, By Country

5.2.4. U.S. Extremities Market

5.2.4.1. Market Size and Forecast, By Product

5.2.5. Canada Extremities Market

5.2.5.1. Market Size and Forecast, By Product

5.2.6. Mexico Extremities Market

5.2.6.1. Market Size and Forecast, By Product

5.3. Europe

5.3.1. Key Market Trends and Opportunities

5.3.2. Market Size and Forecast, By Product

5.3.3. Market Size and Forecast, By Country

5.3.4. France Extremities Market

5.3.4.1. Market Size and Forecast, By Product

5.3.5. Germany Extremities Market

5.3.5.1. Market Size and Forecast, By Product

5.3.6. Italy Extremities Market

5.3.6.1. Market Size and Forecast, By Product

Extremities Market
Global Opportunity Analysis and Industry Forecast, 2023-2032